Company: RVRC
Filing Date: 2025-02-14
Form Type: S-1
Source: 0001213900-25-013823
Chunk: 112

Company: Revium Rx.
Filing Date: 2025-02-14
Form: S-1
Chunk 112
---
 - |   |     |                    |     (3 | ) |     |      |     - |   |
| NET CASH PROVIDED BY INVESTING ACTIVITIES                                   |     |                |   729 |   |     |                |      - |   |     |                    |    (10 | ) |     |      |     - |   |
| CASH FLOWS FROM FINANCING ACTIVITIES:                                       |     |                |       |   |     |                |        |   |     |                    |        |   |     |      |       |   |
| Issuance of ordinary shares                                                 |     |                |     - |   |     |                |      - |   |     |                    |  1,594 |   |     |      |   800 |   |
| Receipt (repayment) of an advance on account of shares                      |     |                |     - |   |     |                |      - |   |     |                    |   (200 | ) |     |      |   200 |   |
| NET CASH PROVIDED BY FINANCE ACTIVITIES                                     |     |                |     - |   |     |                |      - |   |     |                    |  1,394 |   |     |      | 1,000 |   |
| INCREASE IN CASH AND CASH EQUIVALENTS                                       |     |                |   362 |   |     |                |   (457 | ) |     |                    |    370 |   |     |      |   556 |   |
| CASH AND CASH EQUIVALENTS AT THE BEGINNING OF PERIOD                        |     |                | 5,293 |   |     |                |  1,186 |   |     |                    |    816 |   |     |      |   260 |   |
| CASH AND CASH EQUIVALENTS AT THE END OF PERIOD                              |     |                | 5,655 |   |     |                |    729 |   |     |                    |  1,186 |   |     |      |   816 |   |

<div align='center'>The accompanying notes are an integral part of these financial statements.

F-7</div>

REVIUM RX.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

U.S. dollars